Oscar Brochado-Kith
Overview
Explore the profile of Oscar Brochado-Kith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Virseda-Berdices A, Brochado-Kith O, Berenguer J, Gonzalez-Garcia J, Perez-Latorre L, Busca C, et al.
Front Pharmacol
. 2025 Feb;
15:1436198.
PMID: 39911830
Background: HCV eradication with antiviral treatment reduces hepatic disease, but some patients remain at risk of progression to cirrhosis despite HCV clearance. We aimed to examine the association between peripheral...
2.
Martin-Escolano R, Virseda-Berdices A, Berenguer J, Gonzalez-Garcia J, Brochado-Kith O, Fernandez-Rodriguez A, et al.
Front Immunol
. 2025 Jan;
15:1505864.
PMID: 39742264
Various immune checkpoint proteins have been linked to cirrhosis. This study aimed to explore the association between plasma levels of these proteins measured one year after successful HCV treatment and...
3.
Virseda-Berdices A, Martin-Escolano R, Berenguer J, Gonzalez-Garcia J, Brochado-Kith O, Rojo D, et al.
Liver Int
. 2024 Dec;
45(1):e16204.
PMID: 39708286
Background And Aims: In response to direct-acting antivirals (DAAs) therapy, patients who experience a decrease in hepatic venous pressure gradient (HVPG) considerably reduce liver complications and have increased survival. This...
4.
Martin-Escolano R, Virseda-Berdices A, Berenguer J, Gonzalez-Garcia J, Brochado-Kith O, Fernandez-Rodriguez A, et al.
Front Pharmacol
. 2024 Nov;
15:1341612.
PMID: 39530457
Background: Understanding the predictors of metabolic disorders in persons with HIV/HCV coinfection post-HCV therapy is crucial for improving patient outcomes. Since immune checkpoint proteins are usually upregulated in these persons...
5.
Brochado-Kith O, Rava M, Berenguer J, Gonzalez-Garcia J, Rojo D, Diez C, et al.
J Infect Public Health
. 2024 Sep;
17(10):102524.
PMID: 39241484
Background: Altered bacterial translocation is associated with changes in hepatic function and the progression from compensated to decompensated cirrhosis. Child-Turcotte-Pugh (CTP) score is an essential indicator of liver severity. Thus,...
6.
Lara-Aguilar V, Llamas-Adan M, Brochado-Kith O, Crespo-Bermejo C, Grande-Garcia S, Arca-Lafuente S, et al.
J Biomed Sci
. 2024 Aug;
31(1):80.
PMID: 39160510
Background: Around 10% of people with HIV (PWH) exhibit a low-level viremia (LLV) under antiretroviral therapy (ART). However, its origin and clinical significance are largely unknown, particularly at viremias between...
7.
Virseda-Berdices A, Behar-Lagares R, Martinez-Gonzalez O, Blancas R, Bueno-Bustos S, Brochado-Kith O, et al.
Crit Care
. 2024 Aug;
28(1):267.
PMID: 39113075
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes virus-induced-senescence. There is an association between shorter telomere length (TL) in coronavirus disease 2019 (COVID-19) patients and hospitalization, severity, or even death....
8.
Virseda-Berdices A, Martin-Escolano R, Berenguer J, Gonzalez-Garcia J, Brochado-Kith O, Rojo D, et al.
Front Cell Infect Microbiol
. 2024 Mar;
14:1340610.
PMID: 38550617
Background: Combination antiretroviral therapy (ART) has transformed human immunodeficiency virus (HIV) infection in people with HIV (PWH). However, a chronic state of immune activation and inflammation is maintained despite achieving...
9.
Martin-Escolano R, Virseda-Berdices A, Berenguer J, Gonzalez-Garcia J, Brochado-Kith O, Fernandez-Rodriguez A, et al.
Biomed Pharmacother
. 2023 May;
164:114913.
PMID: 37216704
Hepatic steatosis is a common condition found in the liver of hepatitis C virus (HCV)-infected patients, contributing to more severe forms of liver disease. In addition, the human immunodeficiency virus...
10.
Salguero S, Brochado-Kith O, Verdices A, Berenguer J, Gonzalez-Garcia J, Martinez I, et al.
Biomed Pharmacother
. 2023 Apr;
163:114803.
PMID: 37120412
No abstract available.